Hypertonic saline nasal irrigation and gargling should be considered as a treatment option for COVID-19

Sandeep Ramalingam, Catriona Graham, Jenny Dove, Lynn Morrice, Aziz Sheikh

Research output: Contribution to journalArticlepeer-review

Abstract

Post-hoc secondary analysis of data from our recent Edinburgh and Lothians Viral Intervention Study (ELVIS) pilot randomised controlled trial (RCT) indicates that hypertonic saline nasal irrigation and gargling (HSNIG) reduced the duration of coronavirus upper respiratory tract infection (URTI) by an average of two-and-a-half days. As such, it may offer a potentially safe, effective and scalable intervention in those with Coronavirus Disease-19 (COVID-19) following infection with the betacoronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Original languageEnglish
JournalJournal of Global Health
Volume10
Issue number1
Early online date29 Mar 2020
DOIs
Publication statusE-pub ahead of print - 29 Mar 2020

Fingerprint

Dive into the research topics of 'Hypertonic saline nasal irrigation and gargling should be considered as a treatment option for COVID-19'. Together they form a unique fingerprint.

Cite this